Guiyang Xintian Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Guiyang Xintian Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guiyang Xintian Pharmaceutical Co Ltd (002873) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥48.81 Million ≈ $7.14 Million USD) by net assets (CN¥1.26 Billion ≈ $184.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
Cash flow conversion efficiency of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. This chart illustrates how Guiyang Xintian Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002873 stock price and chart for real-time trading data and today's change.
Guiyang Xintian Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Guiyang Xintian Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guiyang Xintian Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guiyang Xintian Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Guiyang Xintian Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
2Seventy Bio Inc
NASDAQ:TSVT
|
-0.051x |
|
Ld Intelligent Technology Co Ltd
SHE:300883
|
0.008x |
|
Zhejiang Zhe Kuang Heavy Industry
SHE:300837
|
0.010x |
|
Camil Alimentos S.A
SA:CAML3
|
0.102x |
|
Kenmare Resources PLC
IR:KMR
|
0.060x |
|
SuRo Capital Corp
NASDAQ:SSSS
|
0.000x |
|
Modern Avenue Group Co Ltd
SHE:002656
|
-0.393x |
|
Integrated Wind Solutions AS
OL:IWS
|
0.055x |
Annual Cash Flow Conversion Efficiency for Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. Review free cash flow generation of Guiyang Xintian Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.26 Billion ≈ $183.83 Million |
CN¥83.73 Million ≈ $12.25 Million |
0.067x | -9.64% |
| 2024-12-31 | CN¥1.19 Billion ≈ $174.82 Million |
CN¥88.13 Million ≈ $12.90 Million |
0.074x | +5.59% |
| 2023-12-31 | CN¥1.11 Billion ≈ $162.92 Million |
CN¥77.78 Million ≈ $11.38 Million |
0.070x | +4.05% |
| 2022-12-31 | CN¥1.13 Billion ≈ $165.24 Million |
CN¥75.82 Million ≈ $11.09 Million |
0.067x | -51.90% |
| 2021-12-31 | CN¥890.44 Million ≈ $130.30 Million |
CN¥124.30 Million ≈ $18.19 Million |
0.140x | -34.22% |
| 2020-12-31 | CN¥828.30 Million ≈ $121.21 Million |
CN¥175.77 Million ≈ $25.72 Million |
0.212x | +345.92% |
| 2019-12-31 | CN¥708.76 Million ≈ $103.71 Million |
CN¥33.73 Million ≈ $4.94 Million |
0.048x | -33.95% |
| 2018-12-31 | CN¥660.59 Million ≈ $96.66 Million |
CN¥47.59 Million ≈ $6.96 Million |
0.072x | -27.78% |
| 2017-12-31 | CN¥622.11 Million ≈ $91.03 Million |
CN¥62.06 Million ≈ $9.08 Million |
0.100x | -54.60% |
| 2016-12-31 | CN¥279.21 Million ≈ $40.86 Million |
CN¥61.34 Million ≈ $8.98 Million |
0.220x | +22.08% |
| 2015-12-31 | CN¥226.31 Million ≈ $33.12 Million |
CN¥40.73 Million ≈ $5.96 Million |
0.180x | -8.09% |
| 2014-12-31 | CN¥190.50 Million ≈ $27.88 Million |
CN¥37.30 Million ≈ $5.46 Million |
0.196x | +122.05% |
| 2013-12-31 | CN¥157.38 Million ≈ $23.03 Million |
CN¥13.88 Million ≈ $2.03 Million |
0.088x | -26.49% |
| 2012-12-31 | CN¥178.44 Million ≈ $26.11 Million |
CN¥21.41 Million ≈ $3.13 Million |
0.120x | -- |
About Guiyang Xintian Pharmaceutical Co Ltd
Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of … Read more